Bioceres CFO files initial insider Form 3

Bioceres Crop Solutions Corp. CFO Ezequiel Simmermacher has filed an initial Form 3, which is the required statement of beneficial ownership for company insiders.

Rhea-AI Filing Summary

Bioceres Crop Solutions Corp. CFO Ezequiel Simmermacher has filed an initial Form 3, which is the required statement of beneficial ownership for company insiders. The filing reports no transactions, meaning there are currently no disclosed purchases, sales, or derivative exercises associated with this insider in this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the BIOX Form 3 filing by CFO Ezequiel Simmermacher show?

The Form 3 for Bioceres Crop Solutions (BIOX) reports CFO Ezequiel Simmermacher's initial beneficial ownership status as an insider. It shows no reported transactions, so no purchases, sales, or option exercises are disclosed in this filing.

Is the BIOX Form 3 filing for Ezequiel Simmermacher a buy or sell signal?

The Form 3 filing for BIOCeres Crop Solutions CFO is not a buy or sell signal. It simply records his status and beneficial ownership as an insider, with no share purchases, sales, or derivative exercises reported in this document.

Does the Bioceres (BIOX) Form 3 include any insider share transactions?

The Form 3 for Bioceres (BIOX) reports no insider share transactions. The transaction summary shows zero buys, zero sells, and no option exercises, indicating only an initial ownership disclosure without trading activity in this filing.

What role does the reporting person in the BIOX Form 3 hold?

The reporting person in the Form 3 for Bioceres Crop Solutions is Ezequiel Simmermacher, who serves as Chief Financial Officer. His status as an officer requires this initial beneficial ownership statement under SEC rules for company insiders.

Why is a Form 3 important for Bioceres Crop Solutions (BIOX) investors?

Form 3 establishes an insider’s baseline beneficial ownership when they become a reporting person. For Bioceres (BIOX), it identifies the CFO as an insider and sets a reference point for any future Form 4 or Form 5 trading disclosures.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/20/2026 - 02:48 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Simmermacher Ezequiel

(Last) (First) (Middle)

CALLE 64 S/N

(Street)

PILAR BUENOS AIRES 1629

(City) (State) (Zip)

ARGENTINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
12/31/2025

3. Issuer Name and Ticker or Trading Symbol
Bioceres Crop Solutions Corp. [ BIOX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Ezequiel Simmermacher	04/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)